Smith, Steven O

Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils

Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 1,111

Inhibitors of Amyloid Toxicity Based on β-sheet Packing of Aβ40 and Aβ42

Sato, T., Kienlen-Campard, P., Ahmed, M., Liu, W., Li, H., Elliott, J. I., Aimoto, S., Constantinescu, S. N., Octave, J.-N., & Smith, S. O. (2006) · Biochemistry

Alzheimer's disease research and treatmentsChemical Synthesis and Analysis

Cited by 191

Structural Role of Glycine in Amyloid Fibrils Formed from Transmembrane α-Helices

Liu, W., Crocker, E., Zhang, W., Elliott, J. I., Luy, B., Li, H., Aimoto, S., & Smith, S. O. (2005) · Biochemistry

Alzheimer's disease research and treatmentsProtein Structure and Dynamics

Cited by 56

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers

Defour, J.-P., Leroy, E., Dass, S., Balligand, T., Levy, G., Brett, I. C., Papadopoulos, N., Mouton, C., Genet, L., Pecquet, C., et al. (2023) · eLife

Receptor Mechanisms and SignalingPlatelet Disorders and Treatments

Cited by 10